153 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
29 May 24
Regulation FD Disclosure
8:05am
by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
7 May 24
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
8:05am
that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create
8-K
EX-99.1
kwqcd8my8wk9u3
24 Jan 24
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
8:01am
8-K
EX-99.1
sqgl ncbcnmmh
11 Jan 24
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-99.1
j2fjsf3bjfvj
14 Nov 23
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:10pm
424B3
zrryeke
5 Sep 23
Prospectus supplement
9:14pm
8-K
EX-99.1
nsfw05rm
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
8-K
EX-99.2
tg9gmssa00 llk5
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
3kgqqteckml41ix
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
1354esc5 judayc
23 Jun 23
Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
4:19pm
8-K
EX-99.1
0qxvryu szwuq6swx
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
8-K
EX-99.1
y3ukn q9d
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm